Earnings watch · ICLR · Healthcare

ICON PLC (ICLR) approaches earnings with rebound intact but confirmation uneven

The clinical-research stock has recovered sharply over 12 weeks, while negative Relative Strength and an inactive trend state keep the setup from looking clean.

Latest146.18 USD
1W move-2.2%
Volume0.9x
TrendInactive
Clinical research office with trial documents, sample vials, and market monitors for ICON PLC earnings coverage.
Supporting market chart for ICON PLC (ICLR) approaches earnings with rebound intact but confirmation uneven

Market update

What happened

ICON PLC (ICLR) closed at 146.18 USD in the latest weekly market data ahead of its June 17 earnings date. The report covers the fiscal quarter ended March 31, with the earnings estimate at 2.18 USD.

The weekly price path over 52 weeks shows a strong medium-term recovery, with the shares up 25.6% over four weeks and 46.6% over twelve weeks. The shorter tape is less supportive: the stock fell 2.2% in the latest week, volume ran at 0.87 times its 13-week average, the trend signal was inactive, and Relative Strength stood at -19.2.

Continue your research

Explore ICLR across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Evidence context